DaVita Inc.
DVA
Rang in Aktien
#1920
DaVita Inc. specializes in delivering essential kidney dialysis treatments and... DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
Aktienkurs
$173.24
Marktkapitalisierung
$11.05B
Veränderung (1 Tag)
-7.45%
Veränderung (1 Jahr)
35.29%
Land
US
Handel DaVita Inc. (DVA)
Kategorie
Healthcare
Umsatz von DaVita Inc. (DVA)
Umsatz im Jun 2026 TTM: $14.01B
Laut den aktuellen Finanzberichten von DaVita Inc. beträgt der derzeitige Umsatz des Unternehmens (TTM) $14.01B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $12.82B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $12.14B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für DaVita Inc. von 2000 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $14.01B | 2.69% |
| 2025 | $13.64B | 6.46% |
| 2024 | $12.82B | 5.56% |
| 2023 | $12.14B | 4.57% |
| 2022 | $11.61B | -0.08% |
| 2021 | $11.62B | 0.59% |
| 2020 | $11.55B | 1.42% |
| 2019 | $11.39B | -0.14% |
| 2018 | $11.40B | 4.86% |
| 2017 | $10.88B | -26.24% |
| 2016 | $14.75B | 6.99% |
| 2015 | $13.78B | 7.71% |
| 2014 | $12.80B | 8.76% |
| 2013 | $11.76B | 43.70% |
| 2012 | $8.19B | 20.53% |
| 2011 | $6.79B | 5.34% |
| 2010 | $6.45B | 5.54% |
| 2009 | $6.11B | 7.93% |
| 2008 | $5.66B | 7.52% |
| 2007 | $5.26B | 7.86% |
| 2006 | $4.88B | 64.12% |
| 2005 | $2.97B | 29.38% |
| 2004 | $2.30B | 12.32% |
| 2003 | $2.05B | 10.34% |
| 2002 | $1.85B | 12.35% |
| 2001 | $1.65B | 11.06% |
| 2000 | $1.49B | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $78.01B | 456.85% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 55.69% |
US
|
|
| $3.89B | -72.20% |
SA
|
|
| $11.08B | -20.88% |
BR
|
